BSX Filing
4Filing Date: May 21, 2026
BOSTON SCIENTIFIC CORP (BSX) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0001225208-26-005548open_in_new
Total Value$100.0K
Trades1
Insiders1
Transaction Details
Pegus Cheryl
Director·Direct
Buy · Acquire
Common Stock
Shares+1.77K
Price$56.49
Total Value$100.0K
Shares Owned After1.77K
Transaction DateMay 20, 2026
Footnotes ▸
Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $56.49 to $56.5009, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Post-Transaction Holdings
Pegus Cheryl
| Security | Shares | Change |
|---|---|---|
| Common Stock | 1.77K | +1.77K |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-05-20
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
--- Reporting Owner ---
Name: Pegus Cheryl
CIK: 0001572448
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-05-20 | Code: P (Open market purchase)
Shares: +1,770 | Price: $56.49
Total Value: $99,987.30
Shares Owned After: 1,770 | Ownership: D (Direct)
Footnotes:
[F1] Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $56.49 to $56.5009, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
--- Footnotes (Complete Index) ---
F1: Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $56.49 to $56.5009, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
--- Signature ---
/s/ /s/ Susan Thompson, Attorney-in-Fact (2026-05-21)